The effect of publication on Internet-based solicitation of personal-injury litigants

CMAJ. Canadian Medical Association Journal

Volumn 177, Issue 11, 2007, Pages 1369-1370

  Juurlink, David N ^a,d   Park Wyllie, Laura Y ^b,d   Kapral, Moira K ^c,d  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GATIFLOXACIN;

ARTICLE; DISORDERS OF CARBOHYDRATE METABOLISM; DYSGLYCEMIA; HUMAN; INTERNET; LAW; LAW SUIT; MEDICAL LITERATURE; MEDICOLEGAL ASPECT; PUBLICATION;

EID: 36749039203     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.070652     Document Type: Article

References (4)

1. Berenson A. Merck inquiry backs conduct over Vioxx. The New York Times 2006 Sept 7. Available: www.nytimes.com/2006/09/07/business/07merck. html?ex =1189828800&en=547fe17ac5544576&ei=5070 (accessed 2007 Oct 12).
2. District of Columbia Bar. Soliciting plaintiffs for class action lawsuits or obtaining legal work through Internet-based Web pages. Washington: The Bar; 2007. Available: www.dcbar.org/for_lawyers/ethics/legal_ethics/opinions/ opinion302.cfm (accessed 2007 Sept 13).
3. Juurlink DN, Mamdani MM, Lee DS, et al. Rates of hyperkalemia after publication of the randomized aldactone evaluation study. N Engl J Med 2004;351:543-51.
4. Park-Wyllie LY, Juurlink DN, Kopp A, et al. Outpatient gatifloxacin therapy and dysglycemia in older adults. N Engl J Med 2006;354:1352-61.